We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Large Genetic Screen Identifies Eight New Variants Linked to Skin Cancer Risk

By LabMedica International staff writers
Posted on 11 Mar 2020
A large genome-wide association study (GWAS) identified eight new gene loci linked to the risk of developing cutaneous squamous cell carcinoma.

Cutaneous squamous cell carcinoma (SCC) is one of the most common cancers in the United States. More...
In contrast to melanoma, SCC usually responds to treatment and rarely spreads to other parts of the body.

Previous genome-wide association studies have identified 14 single nucleotide polymorphisms (SNPs) associated with cutaneous SCC. Investigators at Indiana University (Indianapolis, USA) have expanded this knowledge by performing the largest cutaneous SCC meta-analysis to date, incorporating six international cohorts and totaling 19,149 SCC cases and 680,049 controls.

Results of this study revealed eight novel loci associated with SCC and confirmed the 14 previously associated loci. The investigators also performed fine mapping of the causal gene variants. They found that the novel SNPs occurred within skin-specific regulatory elements and implicated loci involved in cancer development, immune regulation, and keratinocyte differentiation.

Results of the current study have increased the known SCC-related loci to 22. However, these loci account for only 8.5% of the heritable risk for squamous cell skin cancer.

“This is the largest genetic-associated study for squamous cell carcinoma of the skin,” said senior author Dr. Jiali Han, professor of epidemiology at Indiana University. “Our multidisciplinary research sheds light on new biology and the etiology of squamous cell carcinoma, confirming some important genes and also identifying genes involved in this particular cancer development. We can certainly say there is some genetic overlap between squamous cell carcinoma, basal cell carcinoma, and melanoma - the three major types of skin cancer - but we also found some genes are specific for squamous cell carcinoma.”

The SCC genome-wide association study was published in the February 10, 2020, online edition of the journal Nature Communications.

Related Links:
Indiana University


Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
hCG Whole Blood Pregnancy Test
VEDALAB hCG-CHECK-1
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.